Business
Sale of Non-Core Products
Venture Life Group PLC has completed the sale of its Ultradex and Dentyl oral care brands for up to £4.5 million in cash, on a cash-free, debt-free basis. The transaction includes an initial payment of £3.75 million, with a further £0.75 million contingent on future trading performance, and the net proceeds will bolster the company's acquisition strategy and focus on its higher-margin "Power Brands" such as Balance Activ and Health & Her. The divested oral care assets generated £4.3 million in revenue and £0.4 million in adjusted EBITDA for the year ended December 31, 2024, and had a net carrying value of £4.5 million as of November 30, 2025. Disclaimer*
About this update from Venture Life Group Plc
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN\n9 December 2025 \nVENTURE LIFE GROUP PLC\n(\"Venture Life\" or the \"Company\")\nSale of non-core products for up to £4.5m in cash on a cash free, debt free basis\nVenture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that, further to the disclosure made in the FY24 Final Results announcement, it has completed the sale of its Ultradex and Dentyl brands, including 100 per cent. of the issued share capital of Periproducts Limited, (the \"Oral Care Assets\") for an enterprise value of up to £4.5 million (the \"Sale\") on a cash free, debt free basis to Covestus Holdings Ltd.\n \nThe consideration for the Sale is payable in cash, with £3.75m paid to the Company on completion that is subject to customary working capital adjustments. A further amount of up to £0.75m will be payable in cash contingent upon the Oral Care Assets achieving expected trading results for the 12 months post completion. As part of the Sale, the Oral Care Assets and the Company will enter into a transitional services agreement until end of February 2026 to ensure a smooth transition.\n \nThe net proceeds of the Sale will further bolster Venture Life and its subsidiaries (the \"Group\") with additional financial resources for its acquisition strategy.\n \nStrategic rationale\n \nThe Oral Care Assets do not form part of the future strategic direction of the Company and so the decision has been taken to divest of these assets. Venture Life is now focusing its efforts and resources on the Group's higher margin, higher growth core brands in its key target categories, to promote and support the Proactive Healthy Longevity of consumers. Its current core brands include Balance Activ, Health & Her/Him, Lift and Earol, (collectively the \"Power Brands\"), and the funds raised through the Sale will be utilised alongside the existing available funds of the business to drive innovation and growth in the Power...